W. Huinink

发表

Alternative formulations of paclitaxel.

J. Beijnen, B. Nuijen, W. W. Huinink, 1997, Cancer treatment reviews.

The co-solvent Cremophor EL limits absorption of orally administered paclitaxel in cancer patients

J. Schellens, H. Rosing, J. Beijnen, 2001, British Journal of Cancer.

Phase I and pharmacokinetic study of oral paclitaxel.

J. Schellens, H. Rosing, J. Beijnen, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

HIGH-PERFORMANCE LIQUID CHROMATOGRAPHIC METHODS FOR THE DETERMINATION OF A NOVEL POLYMER-BOUND PACLITAXEL DERIVATIVE AND FREE PACLITAXEL IN HUMAN PLASMA

J. Schellens, H. Rosing, J. Beijnen, 2000 .

Coadministration of oral cyclosporin A enables oral therapy with paclitaxel.

J. Schellens, H. Rosing, J. Beijnen, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Bio-analysis of docetaxel and hydroxylated metabolites in human plasma by high-performance liquid chromatography and automated solid-phase extraction.

H. Rosing, J. Beijnen, W. W. ten Bokkel Huinink, 1997, Journal of chromatography. B, Biomedical sciences and applications.

Co-administration of GF120918 significantly increases the systemic exposure to oral paclitaxel in cancer patients

J. Schellens, H. Rosing, J. Beijnen, 2001, British Journal of Cancer.

Clinical pharmacology of anticancer agents in relation to formulations and administration routes.

J. Schellens, J. Beijnen, W. W. Huinink, 1999, Cancer treatment reviews.

Carboplatin Dosage Formulae Can Generate Inaccurate Predictions of Carboplatin Exposure in Carboplatin/Paclitaxel Combination Regimens

G. Giaccone, J. Schellens, J. Beijnen, 1998, Clinical drug investigation.

Increased oral bioavailability of topotecan in combination with the breast cancer resistance protein and P-glycoprotein inhibitor GF120918.

J. Schellens, H. Rosing, J. Beijnen, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Sensitive Determination of the Carboxylate and Lactone Forms of the Novel Antitumor Drug Irinotecan and Its Active Metabolite in Plasma by HPLC

J. Schellens, H. Rosing, J. Beijnen, 1998 .

Isolation and structural confirmation of N-desmethyl topotecan, a metabolite of topotecan

H. Rosing, J. Beijnen, V. Herben, 1997, Cancer Chemotherapy and Pharmacology.

Phase I study of an oral formulation of irinotecan administered daily for 14 days every 3 weeks in patients with advanced solid tumours

J. Schellens, J. Beijnen, G. Sanderink, 2005, Cancer Chemotherapy and Pharmacology.

High Performance Liquid Chromatographic Analysis of The Cardioprotective Agent Dexrazoxane in Human Plasma and Urine

H. Rosing, J. Beijnen, R. Gijn, 1997 .

Phase I and pharmacological study of daily oral administration of perifosine (D-21266) in patients with advanced solid tumours.

J. Schellens, H. Rosing, J. Beijnen, 2002, European journal of cancer.

Oral topotecan: bioavailability and effect of food co-administration

J. Schellens, H. Rosing, J. Beijnen, 1999, British Journal of Cancer.

High-performance liquid chromatographic analysis of the new antitumour drug SK&F 104864-A (NSC 609699) in plasma.

S. Rodenhuis, J. Beijnen, W. W. ten Bokkel Huinink, 1990, Journal of pharmaceutical and biomedical analysis.

Coadministration of cyclosporine strongly enhances the oral bioavailability of docetaxel.

D. Richel, J. Schellens, H. Rosing, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Continuous infusion of low-dose topotecan: pharmacokinetics and pharmacodynamics during a phase II study in patients with small cell lung cancer.

J. Beijnen, W. W. ten Bokkel Huinink, M. Schot, 1998, Anti-cancer drugs.

Clinical Pharmacology of Carboplatin Administered in Alternating Sequence with Paclitaxel in Patients with Non-Small Cell Lung Cancer: A European Cancer Centre (ECC) Study

G. Giaccone, P. Postmus, J. Beijnen, 1996 .

The use of the Calvert formula to determine the optimal carboplatin dosage

S. Rodenhuis, J. Beijnen, R. Maes, 2005, Journal of Cancer Research and Clinical Oncology.